TORONTO
,
Sept. 18
/CNW/ - Oncolytics Biotech Inc. (the "Corporation") announces that at the request of Market Surveillance on behalf of the
Toronto
Stock Exchange that the Corporation is not aware of any material undisclosed information that may be contributing to the recent increase in market price and level of trading activity of its shares.
Share this article